Journal article
Extensively drug-resistant klebsiella pneumoniae causing nosocomial bloodstream infections in China: Molecular investigation of antibiotic resistance determinants, Informing therapy, and clinical outcomes
W Bi, H Liu, RA Dunstan, B Li, VVL Torres, J Cao, L Chen, JJ Wilksch, RA Strugnell, T Lithgow, T Zhou
Frontiers in Microbiology | FRONTIERS MEDIA SA | Published : 2017
Abstract
The rise in diversity of antimicrobial resistance phenotypes seen in Klebsiella pneumoniae is becoming a serious antibiotic management problem. We sought to investigate the molecular characteristics and clinical implications of extensively drug-resistant (XDR) K. pneumoniae isolated from different nosocomial bloodstream infections (BSIs) patients from July 2013 to November 2015. Even in combination treatment, meropenem did not protect against mortality of BSIs patients (P = 0.015). In contrast, tigecycline in combination with other antimicrobial agents significantly protected against mortality (P = 0.016). Antimicrobial susceptibility tests, molecular detection of antibiotic resistance deter..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by research grants from the National Natural Science Foundation of China (no. 81171614), the Health Department of Zhejiang Province of the People's Republic of China (no. 2011KYA106), the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (no. [2012]241), and Program Grant 1092262 from the National Health and Medical Research Council, Australia.